Annual report
7733.TEDINET S100W009
Period2024-04-01 → 2025-03-31
Filed2025-06-19
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥997.3bn | 2024-04-01 → 2025-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥925.8bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥881.9bn | 2022-04-01 → 2023-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥750.1bn | 2021-04-01 → 2022-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥730.5bn | 2020-04-01 → 2021-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥162.5bn | 2024-04-01 → 2025-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥51.4bn | 2023-04-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥159.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥43.6bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥182.3bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥141.7bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥76.8bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥117.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥242.6bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥143.4bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥115.7bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥12.9bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥117.9bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥242.9bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥1.43T | at 2025-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.53T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥1.51T | at 2023-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.36T | at 2022-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥1.18T | at 2021-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥681.1bn | at 2025-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥777.0bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥751.7bn | at 2025-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥757.2bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥641.2bn | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥751.7bn | at 2025-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥757.2bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥640.1bn | at 2023-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥510.2bn | at 2022-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥394.3bn | at 2021-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥252.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥340.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥205.5bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥302.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥217.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥190.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥42.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥98.5bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥169.7bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥124.1bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥65.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥360.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥58.4bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥71.0bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥118.9bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥211.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥276.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥143.2bn | 2022-04-01 → 2023-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥40.7bn | 2021-04-01 → 2022-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥40.8bn | 2020-04-01 → 2021-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥102.99 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥199.91 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥113.22 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥90.22 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥10.05 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥102.8 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥199.44 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥113.08 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥90.17 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥10.04 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥666.54 | at 2025-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥649.59 | at 2024-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥510.62 | at 2023-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥400.75 | at 2022-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥306.72 | at 2021-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 52.5% | at 2025-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.4% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 42.4% | at 2023-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 37.6% | at 2022-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 33.3% | at 2021-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 15.6% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 34.7% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 24.9% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 25.6% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 3.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 29,297 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 28,838 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 32,805 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 31,557 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 31,653 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥389.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥379.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥380.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥378.6bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥344.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥12.5bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥41.9bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥69.5bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥135.1bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥152.3bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥57.2bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥49.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥70.4bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥382.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥61.7bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥293.6bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥130.3bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥84.8bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥913.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥954.9bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥973.6bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥900.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥826.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥455.8bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥442.0bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥457.2bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥512.9bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥418.3bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥357.2bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥349.8bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥112.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥190.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥53.89 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥241.97 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥102.88 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥66.13 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.64 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥53.79 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥241.41 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥102.76 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥66.1 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥6.64 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥16 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥12 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥405.22 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥439.81 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥333.48 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥280.3 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥271.69 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 50.1% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.7% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.9% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.7% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 63.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 33.6% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 24.0% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,139,116,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,215,147,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,266,179,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,299,294,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,370,915,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2,494 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 2,834 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 2,727 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 3,478 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 4,775 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥5m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 26 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥5.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥473m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥6.9bn |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥280.4bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥39.9bn |
| Endoscopicreportable segment | employees | at 2025-03-31 | 16139 pure |
| Endoscopic Solutionsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥56.5bn |
| Endoscopic Solutionsreportable segment | segment assets | at 2025-03-31 | ¥672.5bn |
| Endoscopic Solutionsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥141.4bn |
| Therapeuticreportable segment | employees | at 2025-03-31 | 8399 pure |
| Therapeutic Solutionsreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥21.6bn |
| Therapeutic Solutionsreportable segment | segment assets | at 2025-03-31 | ¥474.5bn |
| Therapeutic Solutionsreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥61.5bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥78.1bn |
| —segment total | segment assets | at 2025-03-31 | ¥1.15T |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥202.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥3.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥287m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥9.3bn |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥424.1bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥44.5bn |
| Endoscopic Solutionsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥50.7bn |
| Endoscopic Solutionsreportable segment | segment assets | at 2024-03-31 | ¥637.0bn |
| Endoscopic Solutionsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥104.7bn |
| Therapeutic Solutionsreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥19.3bn |
| Therapeutic Solutionsreportable segment | segment assets | at 2024-03-31 | ¥469.2bn |
| Therapeutic Solutionsreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥8.5bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥70.0bn |
| —segment total | segment assets | at 2024-03-31 | ¥1.11T |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥96.2bn |
| Endoscopicreportable segment | employees | at 2025-03-31 | 963 pure |
| Therapeuticreportable segment | employees | at 2025-03-31 | 331 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,960
| Item | Context | Value | Unit |
|---|---|---|---|
| Intangible assets IFRS | Prior1YearInstant | 91961000000 | JPY |
| Intangible assets IFRS | CurrentYearInstant | 93971000000 | JPY |
| Retirement benefit asset nca IFRS | Prior1YearInstant | 36815000000 | JPY |
| Retirement benefit asset nca IFRS | CurrentYearInstant | 40510000000 | JPY |
| Investments accounted for using equity method IFRS | Prior1YearInstant | 479000000 | JPY |
| Investments accounted for using equity method IFRS | CurrentYearInstant | 482000000 | JPY |
| Trade and other receivables nca IFRS | Prior1YearInstant | 55764000000 | JPY |
| Trade and other receivables nca IFRS | CurrentYearInstant | 64200000000 | JPY |
| Other financial assets nca IFRS | Prior1YearInstant | 34146000000 | JPY |
| Other financial assets nca IFRS | CurrentYearInstant | 43440000000 | JPY |
| Deferred tax assets IFRS | Prior1YearInstant | 72324000000 | JPY |
| Deferred tax assets IFRS | CurrentYearInstant | 65400000000 | JPY |
| Other non current assets nca IFRS | Prior1YearInstant | 2088000000 | JPY |
| Other non current assets nca IFRS | CurrentYearInstant | 1779000000 | JPY |
| Non current assets IFRS | Prior1YearInstant | 733876000000 | JPY |
| Non current assets IFRS | CurrentYearInstant | 753383000000 | JPY |
| Assets IFRS | Prior1YearInstant | 1534216000000 | JPY |
| Assets IFRS | CurrentYearInstant | 1432826000000 | JPY |
| Trade and other payables cl IFRS | Prior1YearInstant | 61855000000 | JPY |
| Trade and other payables cl IFRS | CurrentYearInstant | 61415000000 | JPY |
| Bonds and borrowings cl IFRS | Prior1YearInstant | 69988000000 | JPY |
| Bonds and borrowings cl IFRS | CurrentYearInstant | 94985000000 | JPY |
| Other financial liabilities cl IFRS | Prior1YearInstant | 27673000000 | JPY |
| Other financial liabilities cl IFRS | CurrentYearInstant | 21829000000 | JPY |
| Income taxes payable cl IFRS | Prior1YearInstant | 38658000000 | JPY |
| Income taxes payable cl IFRS | CurrentYearInstant | 42451000000 | JPY |
| Provisions cl IFRS | Prior1YearInstant | 31318000000 | JPY |
| Provisions cl IFRS | CurrentYearInstant | 16001000000 | JPY |
| Other current liabilities cl IFRS | Prior1YearInstant | 202203000000 | JPY |
| Other current liabilities cl IFRS | CurrentYearInstant | 188680000000 | JPY |
| Liabilities other than liabilities directly associated with assets held for sale IFRS | Prior1YearInstant | 431695000000 | JPY |
| Liabilities other than liabilities directly associated with assets held for sale IFRS | CurrentYearInstant | 425361000000 | JPY |
| Total current liabilities IFRS | Prior1YearInstant | 431695000000 | JPY |
| Total current liabilities IFRS | CurrentYearInstant | 425361000000 | JPY |
| Bonds and borrowings ncl IFRS | Prior1YearInstant | 229628000000 | JPY |
| Bonds and borrowings ncl IFRS | CurrentYearInstant | 134117000000 | JPY |
| Other financial liabilities ncl IFRS | Prior1YearInstant | 62238000000 | JPY |
| Other financial liabilities ncl IFRS | CurrentYearInstant | 62802000000 | JPY |
| Retirement benefit liability ncl IFRS | Prior1YearInstant | 20586000000 | JPY |
| Retirement benefit liability ncl IFRS | CurrentYearInstant | 19800000000 | JPY |
| Income taxes payable ncl IFRS | Prior1YearInstant | － | JPY |
| Income taxes payable ncl IFRS | CurrentYearInstant | 4743000000 | JPY |
| Provisions ncl IFRS | Prior1YearInstant | 2362000000 | JPY |
| Provisions ncl IFRS | CurrentYearInstant | 2095000000 | JPY |
| Deferred tax liabilities IFRS | Prior1YearInstant | 11989000000 | JPY |
| Deferred tax liabilities IFRS | CurrentYearInstant | 13632000000 | JPY |
| Other non current liabilities ncl IFRS | Prior1YearInstant | 18532000000 | JPY |
| Other non current liabilities ncl IFRS | CurrentYearInstant | 18543000000 | JPY |
| Non current labilities IFRS | Prior1YearInstant | 345335000000 | JPY |
| Non current labilities IFRS | CurrentYearInstant | 255732000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |